Lastly, the authors could show a differential sensitivity of spleen tyrosine kinase (SYK) inhibition in ABC-DLBCL PDX models, compared to GCB-DLBCL PDX models (144). This evidence concerns the gene SYK and diffuse large B-cell lymphoma.